{tabulizer:include style[gr.alterora.elemental_2_blue.css] id[tab_wappgXKX5y]}

MONDAY MAY 05 2014
Abstracts selected for presentation will be available online by April 15, 2014
PLENARY SESSIONS
08:00-09:00 PL01 The revolution in epilepsy genetics changes clinical practice Ingrid Scheffer, Australia
09:00-10:00 PL02 What can we reasonably expect from stem cell therapy- beyond the hype and the hope? Alan Mackay-Sim, Australia
10:00-10:30 COFFEE & POSTER VIEWING / TRADE EXHIBITION
CONCURRENT SYMPOSIA
CATARATAS I
10:30-12:30 S01 Focal Epilepsies - Advances in Genetics 
  Chair: Ingrid Scheffer (Australia)
Familial focal epilepsy with variable foci – a common molecular focal epilepsy Ingrid Scheffer , Australia
How to approach molecular testing of focal epileptic encephalopathies  Heather Mefford, USA
Migrating focal seizures of infancy, a genetic epileptic encephalopathy Rima Nabbout, France
Autosomal dominant nocturnal frontal lobe epilepsy – not just a disorder of nicotinic receptors Shinichi Hirose, Japan
CATARATAS II
10:30-12:30 S02 Autoimmune Neuropsychiatric Disorders 
  Chair: Hilla Ben-Pazi, Israel
Should PANDAS/ CANS be considered separate entity? Hilla Ben-Pazi , Israel
Sydenham's chorea: What in new in this old disorder? Francisco E.C. Cardoso, Brazil
 Neuroinflammation in Opsoclonus-Myoclonus Syndrome: What's New? Michael R Pranzatelli, USA
Pathophysiologic role of anti-NMDA, anti-VGKC and anti-dopamine receptor autoantibodies Russell Dale, Australia
IGUAÇU I
10:30-12:30 S03 Neurometabolic Disorders - Treatment Update 
  Chairs: Ingrid Tein (Canada) / Linda DeMeirleir (Canada)
Treatment update in fatty acid oxidation disorders Ingrid Tein, Canada
Treatment update in lysosomal storage disorders Linda DeMeirleir, Belgium
Treatment update in neuronal ceroid lipofuscinoses Rose-Mary Boustany, Lebanon
Treatment update in mitochondrial disorders  
IGUAÇU II   
10:30-12:30 S04 Brain Stimulation in Children - Neurophysiology and Therapeutics 
  Chair: Adam Kirton (Canada)
Measuring, Mapping, and Modulating Cortical Inhibition and Neuroplasticity in Tourette Syndrome and ADHD Donald Gilbert, USA
Translational brain stimulation: informing clinical protocols in children by basic research Alexander Rotenberg, USA
Enhancing developmental neuroplasticity after perinatal stroke with non-invasive brain stimulation Adam Kirton , Canada
DBS for Childhood Dystonias: Who to select and how to Measure Outcomes? Jean-Pierre Lin, UK
12:30-14:00 LUNCH  / TRADE EXHIBITION / LUNCH TIME MEETINGS
PLATFORM SESSIONS
IGUAÇU I
  CEREBRAL PALSY & NEURODISABILITY
Chair: TBA
0200 - 0215 PM FP01 Glial Precursor Cell Transplantation Improves Behavioral and Neuropathological Outcome in a Model of Neonatal White Matter Injury Ali Fatemi, USA
0215 - 0230 PM FP02 Go for the Cause: Significant Genomic Rearrangements in Cryptogenic Cerebral Palsy Hilla Ben-pazi, Israel
0230 - 0245 PM FP03 Development of a portable electronic goniodynamometer for the evaluation of equinus foot in cerebral palsy. Eduardo Fusão, Brazil
0245 - 0300 PM FP04 Repetitive transcranial magnetic stimulation effects on motor learning in perinatal stroke: Short-term outcomes from the PLASTIC CHAMPS trial. Adam Kirton, Canada
0300 - 0315 PM FP05 Comparative Study of Baclofen and Tizanidine in Reducing Spasticity in Cerebral Palsy- A Randomized Controlled Trial Narayan Saha, Bangladesh
0315 - 0330 PM FP06 Cerebellar vermal involvement in patients with hypoxic-ischemic encephalopathy and relation to cognitive functions. Heba El Khashab, Egypt
0330 - 0345 PM FP07 Prevalence & Risk Factors for neurological disorders in children aged 9-15 years in northern India Rashmi Kumar, India
0345 - 0400 PM FP08 Neurological manifestations of Incontinentia Pigmenti Inmaculada Carreras Sáez, Spain
0400 - 0415 PM FP09 Hemiplegic Cerebral Palsy- Etiology , clinical features and outcome Eli Lahat, Israel
0415 - 0430 PM FP10 Psychiatric Disorder associated with Cerebral Palsy Alessandra Freitas Russo, Brazil
0430- 0445 PM FP11 The biomechanical methods of gait evaluation in children with cerebral palsy IIona Kopyta, Poland
0445 - 0500 PM FP12 Concerns and felt needs of parents of disabled children living in urban slums Samata Singhi, USA
IGUAÇU II
  NEUROGENETICS
Chair: TBA
0200 - 0215 PM FP21 De Novo DiGenic Heterozygous Mutations in EZR and NR2E3 revealed by Exome Sequencing in a patient with Cataract, Retinal Degeneration, Epilepsy and Leukodystrophy Majed Dasouki, Saudi Arabia
0215 - 0230 PM FP14 Identification of genes for autosomal recessive microcephaly by whole-exome sequencing Ganeshwaran Mochida, USA
0230 - 0245 PM FP15 Outcome of Hematopoietic Stem Cell Tranplant (HCT) in childhood cerebral Adrenoleukodystrophy (CCALD): a Multi-Institutional Study Asif Paker, USA
0245 - 0300 PM FP16 Patient-derived stem cells as models for familial brain disorders Alan Mackay-Sim, Australia
0300 - 0315 PM FP17 An approach to genotype-phenotype correlation in rett syndrome Paulina Carullo, Argentina
0315 - 0330 PM FP18 Episodic weakness, cerebellar ataxia, deafness and optic atrophy - a new phenotype of a novel ATP1A3 mutation Bruria Ben-Zeev, Israel
0330 - 0345 PM FP19 Molecular characterization in children with attention deficit and hyperactivity disorder Alberto Velez Van Meerbeke, Colombia
0345 - 0400 PM FP20 Novel MLC1 and GLIACAM mutations analysis and follow-up study in Chinese patients with Megalencephalic Leukoencephalotathy with Subcortical Cysts Jingmin Wang, China
0400 - 0415 PM FP13  Expanding the Genetic Landscape of Neurodevelopmental Disorders with Whole Exome Sequencing Ali Fatemi, USA
0415 - 0430 PM FP22 Follow up study of 34 Chinese patients with vanishing white matter disease and role of UPR and autophagy in the pathogenesis Ye Wu, China
0430 - 0445 PM FP23 Proteolipid protein 1 and gap junction α12 gene mutations in 72 Chinese patients with Pelizaeus-Merzbacher disease/ Pelizaeus-Merzbacher like disease and prenatal diagnosis of 15 fetuses in twelve Chinese families with PMD probands Jingmin Wang, China
0445 - 0500 PM FP24 The 9p13 Deletion Syndrome: Confirmation and Expansion of the Phenotype Majed Dasouki, Saudi Arabia
CATARATAS I
  EPILEPSY
Chair: TBA
0200 - 0215 PM FP37 Bone Health Screening Practices Amongst Boston Children's Hospital Neurologists in Pediatric Epilepsy Patients: Follow Up on a Quality Improvement Project Kristina Julich, USA
0215 - 0230 PM FP38 Clinical, EEG and imaging characteristics of children with Sturge-Weber syndrome: A prospective, longitudinal study Csaba Juhasz, USA
0230 - 0245 PM FP39 High prevalence of autoantibodies to N-methyl-D-aspartate receptor and the efficacy of glucocorticoids in PCDH19-related female-limited epilepsy Norimichi Higurashi, Japan
0245 - 0300 PM FP40 Early epileptic encephalopathy with suppression-burst revealing RFT1-CDG Alec Aeby, Belgium
0300 - 0315 PM FP41 Clinical markers of Postictal Generalized EEG Suppression (PGES) in children Elizabeth Kouzmitcheva, Canada
0315 - 0330 PM FP42 Who are the super responders to the ketogenic diet? Janak Nathan, India
0330 - 0345 PM FP43 Successful use of Fenfluramine as add-on treatment in Dravet syndrome: A three years prospective follow-up Berten Ceulemans, Belgium
0345 - 0400 PM FP44 Usefulness of video-eeg monitoring in children Marina Aberastury, Argentina
0400- 0415 PM FP45 Trajectories of Health and Well-being in Children with Epilepsy: Hypotheses and Methodology of a Canadian Longitudinal Study Gabriel Ronen, Canada
0415 - 0430 PM FP46 Using Self-Regulation concepts to predict sleep problems in adolescents with epilepsy Antigone Papavasiliou, Greece
0430 - 0445 PM FP47 Clinico etiological profile of infantile onset epilepsy at a tertiary care center in India Ramesh Konanki, India
0445- 0500 PM FP48 The association of febrile seizure and single nucleotide polymorphism of cyclooxygenase-2 Kun-long Hung, Taiwan
0500-0515 PM FP49  Infantile spasms: Ictal video-EEG classification based on the Delphi West Group proposal  Marina Aberastury, Argentina
0515-0530 PM FP50 Correlation between social competence and neurocognitive performance in children with epilepsy Anneli Kolk, Estonia
CATARATAS II
  MOVEMENT DISORDERS
Chair: TBA
0200 - 0215 PM FP25 Movement Disorders in the Neuronal Ceroid Lipofusinoses Jonathan Mink, USA
0215 - 0230 PM FP26 Coprophenomena are Associated with High Clinical Impact in Tourette Syndrome Jonathan Mink, USA
0230 - 0245 PM FP27 Pediatric Dystonia: DBS and Diversity in Diencephalic Dysfunction Aaron Cardon, USA
0245 - 0300 PM FP28 Methodology of approaches to childhood hereditary ataxias Elif Acar Arslan, Turkey
0300 - 0315 PM FP29 PLA2G6 gene mutations cause evolving spinocerebellar ataxia influenced by the genotype Mustafa Salih, Saudi Arabia
0315 - 0330 PM FP30 Developmental stages of Basal Ganglia reflects Movement Disorders in Childhood Masaya Segawa, Japan
0330 - 0345 PM FP31 Phenotypical and Molecular Characterization of Patients with Neurodegeneration with Brain Iron Accumulation (NBIA) due to PKAN2 gene mutations Felippe Borlot, Canada
0345 - 0400 PM FP32 An open label clinical pilot study of resveratrol as a treatment for Friedreich ataxia Eppie Yiu, Australia
0400- 0415 PM FP33 Movement disorder phenomenology helps differentiate NMDAR encephalitis from autoimmune basal ganglia encephalitis Shekeeb Mohammad, Australia
0415 - 0430 PM FP34 Favorable response to acetazolamide in a case of glut-1 deficiency Paulina Carullo, Argentina
0430 - 0445 PM FP35 ATP1A3 Mutations and Genotype-Phenotype Correlation of Alternating Hemiplegia of Childhood in Chinese Patients Yuehua Zhang, China
0445- 0500 PM FP36 Treatment of Tremor in Cerebral Palsy with Deep Brain Stimulation Aimee Morris, USA

pleasedonate